MedTrace Logo

COVID-19 Immune Repertoire Sequencing

NCT04368143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2023-10-02

No results posted yet for this study

Summary

This concerns a single-center prospective interventional cohort study. Laboratory-confirmed COVID-19 patients will be asked to donate blood at at least two different timepoints. This will allow us to investigate T and B cell evolutions during the course of infection and recovery. The expected duration of the study is four months or the total duration of the SARS-CoV-2 circulation in Belgium (whichever is shortest).

Conditions

  • COVID
  • SARS-CoV 2
  • Corona Virus Infection
  • RDT
  • B Cell

Sponsors & Collaborators

  • University Hospital, Antwerp

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2021-12-02
Completion
2021-12-02

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04368143 on ClinicalTrials.gov